Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    NCT01491737
Show Display Options
Rank Status Study
1 Active, not recruiting A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Participants With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive and Hormone Receptor-Positive Advanced Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Pertuzumab;   Drug: Trastuzumab;   Drug: Aromatase Inhibitor;   Drug: Induction Chemotherapy

Study has passed its completion date and status has not been verified in more than two years.